{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:51:22Z","timestamp":1762325482891,"version":"3.41.2"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Substance use (SU) contributes to poor health outcomes, yet limited data exist to inform strategies to optimize SU treatment among persons with human immunodeficiency virus (HIV). We describe SU and SU treatment utilization among women with and without HIV in the Women's Interagency HIV Study (WIHS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included data from women enrolled in WIHS from 2013 to 2020. Current SU was self-reported, nonmedical use of drugs in the past year, excluding use of only marijuana. SU treatment utilization was self-reported use of a drug treatment program in the past year. Multivariable regression models were used to investigate associations between participant characteristics and SU treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 2559 women (1802 women living with HIV [WWH], 757 women without HIV), 14% reported current SU. Among those with current SU (n = 367), 71% reported crack\/cocaine followed by 40% reporting opioids, and 42% reported any treatment in the past year. The most common treatments were methadone (64%), Narcotics Anonymous (29%), inpatient programs (28%), and outpatient programs (16%). Among women using opioids (n = 147), 67% reported methadone use in the past year compared to 5% using buprenorphine\/naloxone. Multivariable analysis showed lower odds of treatment utilization among WWH with concurrent alcohol or marijuana use. Visiting a psychiatrist\/counselor was associated with higher odds of treatment. Among WWH, SU treatment was not associated with HIV-related clinical outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Treatment utilization was high, especially for methadone use. Our results highlight opportunities for accessing SU treatment for WWH, such as the need to prioritize buprenorphine and comprehensive, wraparound services in HIV care settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac684","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T06:12:59Z","timestamp":1671689579000},"source":"Crossref","is-referenced-by-count":4,"title":["Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-6434","authenticated-orcid":false,"given":"Ayako W","family":"Fujita","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0843-1414","authenticated-orcid":false,"given":"Aditi","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"},{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St Louis , St Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Christina","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oyindamola B","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, School of Public Health, State University of New York Downstate Health Sciences University , Brooklyn, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Shoptaw","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles , Los Angeles, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam W","family":"Carrico","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Miami Miller School of Medicine , Miami, Florida , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adaora A","family":"Adimora","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Eaton","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama School of Medicine , Birmingham, Alabama , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mardge H","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stroger Hospital of Cook County , Chicago, Illinois , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Infectious Diseases, University of California, San Francisco , San Francisco, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebola","family":"Adedimeji","sequence":"additional","affiliation":[{"name":"Division of Health Behavior Research and Implementation Science, Department of Epidemiology and Population Health, Albert Einstein College of Medicine , Bronx, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Plankey","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Georgetown University Medical Center , Washington, District of Columbia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-8891","authenticated-orcid":false,"given":"Deborah","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine , Miami, Florida , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Chandran","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A","family":"Colasanti","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"},{"name":"Infectious Disease Program, Grady Health System , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6305-2727","authenticated-orcid":false,"given":"Anandi N","family":"Sheth","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"2023011214432166600_ofac684-B1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s10461-016-1584-6","article-title":"Prevalence and predictors of substance use disorders among HIV care enrollees in the United States","volume":"21","author":"Hartzler","year":"2017","journal-title":"AIDS Behav"},{"key":"2023011214432166600_ofac684-B2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200666060-00004","article-title":"Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy","volume":"66","author":"Chander","year":"2006","journal-title":"Drugs"},{"key":"2023011214432166600_ofac684-B3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","article-title":"Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users","volume":"17","author":"Arnsten","year":"2002","journal-title":"J Gen Intern Med"},{"key":"2023011214432166600_ofac684-B4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00126334-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4 Suppl 3","key":"2023011214432166600_ofac684-B5","first-page":"iii7","article-title":"The role of sexual transmission of HIV infection among injection and non-injection drug users","volume":"80","author":"Strathdee","year":"2003","journal-title":"J Urban Health"},{"key":"2023011214432166600_ofac684-B6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"author":"The White House","key":"2023011214432166600_ofac684-B7"},{"first-page":"1","year":"2013","author":"Lipari","key":"2023011214432166600_ofac684-B8"},{"key":"2023011214432166600_ofac684-B9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(10)61026-4","article-title":"HIV and women who use drugs: double neglect, double risk","volume":"376","author":"El-Bassel","year":"2010","journal-title":"Lancet"},{"key":"2023011214432166600_ofac684-B10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jsat.2013.12.008","article-title":"Gender disparities in utilization and outcome of comprehensive substance abuse treatment among racial\/ethnic groups","volume":"46","author":"Guerrero","year":"2014","journal-title":"J Subst Abuse Treat"},{"key":"2023011214432166600_ofac684-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: a review of the literature","volume":"86","author":"Greenfield","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"2023011214432166600_ofac684-B12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2017.10.003","article-title":"The effects of opioid-agonist treatments on HIV risk and social stability: a mixed methods study of women with opioid use disorder in Ukraine","volume":"83","author":"Hoff","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"2023011214432166600_ofac684-B13","first-page":"1013","article-title":"The Women's Interagency HIV study: an observational cohort brings clinical sciences to the bench","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2023011214432166600_ofac684-B14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ije\/dyy021","article-title":"Cohort profile: the Women's Interagency HIV Study (WIHS)","volume":"47","author":"Adimora","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2023011214432166600_ofac684-B15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Women's Interagency HIV Study. WIHS Collaborative Study Group","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"2023011214432166600_ofac684-B16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11904-019-00422-z","article-title":"The association between marijuana use and HIV continuum of care outcomes: a systematic review","volume":"16","author":"Montgomery","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2023011214432166600_ofac684-B17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsat.2017.09.009","article-title":"Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic","volume":"82","author":"Sinha","year":"2017","journal-title":"J Subst Abuse Treat"},{"author":"National Institute on Alcohol Abuse and Alcoholism","key":"2023011214432166600_ofac684-B18"},{"key":"2023011214432166600_ofac684-B19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.15288\/jsad.2016.77.160","article-title":"The relationship between client characteristics and wraparound services in substance use disorder treatment centers","volume":"77","author":"Paino","year":"2016","journal-title":"J Stud Alcohol Drugs"},{"key":"2023011214432166600_ofac684-B20","first-page":"e2264","article-title":"Wraparound programmes for pregnant and parenting women with substance use concerns in Canada: partnerships are essential","volume":"30","author":"Hubberstey","year":"2021","journal-title":"Health Soc Care Community"},{"key":"2023011214432166600_ofac684-B21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10903-019-00933-2","article-title":"Women's barriers to specialty substance abuse treatment: a qualitative exploration of racial\/ethnic differences","volume":"22","author":"Pinedo","year":"2020","journal-title":"J Immigr Minor Health"},{"key":"2023011214432166600_ofac684-B22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1300\/J233v04n01_05","article-title":"Experiences with and perceptions of, barriers to substance abuse and HIV services among African American women who use crack cocaine","volume":"4","author":"MacMaster","year":"2005","journal-title":"J Ethn Subst Abuse"},{"key":"2023011214432166600_ofac684-B23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.15288\/jsad.2018.79.853","article-title":"Substance use disorders among veterans in a nationally representative sample: prevalence and associated functioning and treatment utilization","volume":"79","author":"Boden","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"key":"2023011214432166600_ofac684-B24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023011214432166600_ofac684-B25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial\u2012ethnic disparities of buprenorphine and vivitrol receipt in Medicaid","volume":"63","author":"Dunphy","year":"2022","journal-title":"Am J Prev Med"},{"key":"2023011214432166600_ofac684-B26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac909","article-title":"Prevalence, distribution, and characteristics associated with possession of buprenorphine waivers among infectious diseases physicians in the United States [manuscript published online ahead of print 24 November 2022]","author":"Fujita","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023011214432166600_ofac684-B27","doi-asserted-by":"crossref","first-page":"108710","DOI":"10.1016\/j.drugalcdep.2021.108710","article-title":"Growing racial\/ethnic disparities in buprenorphine distribution in the United States, 2007\u20132017","volume":"223","author":"Schuler","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2023011214432166600_ofac684-B28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08897077.2017.1363844","article-title":"Utilization of buprenorphine and methadone among opioid users who inject drugs","volume":"39","author":"Tsui","year":"2018","journal-title":"Subst Abus"},{"key":"2023011214432166600_ofac684-B29","first-page":"1","article-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update)","author":"Alderks","year":"2013"},{"key":"2023011214432166600_ofac684-B30","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"2023011214432166600_ofac684-B31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.annemergmed.2021.03.023","article-title":"Improve access to care for opioid use disorder: a call to eliminate the X-waiver requirement now","volume":"78","author":"D'Onofrio","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"6 Suppl 3","key":"2023011214432166600_ofac684-B32","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy pathways to address provider workforce barriers to buprenorphine treatment","volume":"54","author":"Haffajee","year":"2018","journal-title":"Am J Prev Med"},{"issue":"Suppl 1","key":"2023011214432166600_ofac684-B33","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV Treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"2023011214432166600_ofac684-B34","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/QAI.0b013e3182097537","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone","volume":"56","author":"Fiellin","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023011214432166600_ofac684-B35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial","volume":"152","author":"Lucas","year":"2010","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"2023011214432166600_ofac684-B36","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","article-title":"Integration of buprenorphine\/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative","volume":"56","author":"Weiss","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023011214432166600_ofac684-B37","doi-asserted-by":"crossref","first-page":"109241","DOI":"10.1016\/j.drugalcdep.2021.109241","article-title":"Safer in care: a pandemic-tested model of integrated HIV\/OUD care","volume":"231","author":"Eaton","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"2023011214432166600_ofac684-B38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1475-6773.12686","article-title":"Geographic disparities in availability of opioid use disorder treatment for medicaid enrollees","volume":"53","author":"Abraham","year":"2018","journal-title":"Health Serv Res"},{"key":"2023011214432166600_ofac684-B39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamapsychiatry.2013.3575","article-title":"Race\/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States","volume":"71","author":"Cummings","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"2023011214432166600_ofac684-B40","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/aje\/kwab050","article-title":"Characteristics of the MACS\/WIHS combined cohort study: opportunities for research on aging with HIV in the longest US observational study of HIV","volume":"190","author":"D'Souza","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2023011214432166600_ofac684-B41","doi-asserted-by":"crossref","first-page":"e30398","DOI":"10.2196\/30398","article-title":"Study of treatment and reproductive outcomes among reproductive-age women with HIV infection in the southern United States: protocol for a longitudinal cohort study","volume":"10","author":"Sheth","year":"2021","journal-title":"JMIR Res Protoc"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac684\/48329809\/ofac684.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/1\/ofac684\/48651440\/ofac684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/1\/ofac684\/48651440\/ofac684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T19:34:59Z","timestamp":1673552099000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac684\/6953332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac684","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,12,21]]},"article-number":"ofac684"}}